Fatal Overdose Reduction Act of 2024

The Fatal Overdose Reduction Act of 2024 (S 4430) establishes a Medicaid demonstration program to create "Health Engagement Hubs" that provide integrated, walk-in care for people with substance use disorders, particularly in underserved communities disproportionately affected by overdoses. These hubs must offer harm reduction services, immediate access to FDA-approved medications (like buprenorphine), mental health support, and care coordination - including housing, employment, and legal assistance - without appointments or prior payment. States must prioritize locations in areas with high overdose death rates or health professional shortages, and hubs must include staff with lived experience in substance use. The program provides federal funding through a state-designed payment system and requires annual reports on outcomes like overdose rates and treatment adherence.